Community-based phase IIIB trial of three UPFRONT bortezomib-based myeloma regimens.
Journal of Clinical Oncology.
Times cited: 74
Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: A comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events.
European Journal of Cancer.
Times cited: 45